Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2008 1
2009 2
2010 4
2011 6
2012 1
2013 3
2014 4
2015 7
2016 8
2017 9
2018 5
2019 13
2020 4
2021 10
2022 9
2023 4
2024 5
2025 5
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, Tettero JM, Bachas C, Baer C, Béné MC, Bücklein V, Czyz A, Denys B, Dillon R, Feuring-Buske M, Guzman ML, Haferlach T, Han L, Herzig JK, Jorgensen JL, Kern W, Konopleva MY, Lacombe F, Libura M, Majchrzak A, Maurillo L, Ofran Y, Philippe J, Plesa A, Preudhomme C, Ravandi F, Roumier C, Subklewe M, Thol F, van de Loosdrecht AA, van der Reijden BA, Venditti A, Wierzbowska A, Valk PJM, Wood BL, Walter RB, Thiede C, Döhner K, Roboz GJ, Cloos J. Heuser M, et al. Among authors: plesa a. Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626. Blood. 2021. PMID: 34724563 Free PMC article.
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.
Cloos J, Valk PJM, Thiede C, Döhner K, Roboz GJ, Wood BL, Walter RB, Wang S, Wierzbowska A, Wei AH, Wu D, Vergez F, Venditti A, van der Reijden BA, van de Loosdrecht AA, Tiong IS, Thol FR, Subklewe M, Roumier C, Reuvekamp T, Ravandi F, Preudhomme C, Plesa A, Othman J, Ossenkoppele GJ, Ofran Y, Mimoun A, Maurillo L, Majchrzak A, de Leeuw D, Kern W, Kim DDH, Ikoma-Colturato MRV, Haaksma LH, Guzman ML, Feuring M, Depreter B, Czyz A, Bücklein V, Baer C, Bachas C, Freeman SD, Buccisano F, Hourigan CS, Dillon R, Heuser M. Cloos J, et al. Among authors: plesa a. Blood. 2026 Mar 12;147(11):1147-1167. doi: 10.1182/blood.2025031480. Blood. 2026. PMID: 41397238 Review.
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.
Garciaz S, Dumas PY, Bertoli S, Sallman DA, Decroocq J, Belhabri A, Orvain C, Aspas Requena G, Simand C, Laribi K, Carré M, Santagostino A, Himberlin C, Peterlin P, Bonnet S, Chan O, Lancet J, Komrokji R, Vergez F, Chapuis N, Raskovalova T, Plesa A, Lhoumeau AC, Mineur A, Hospital MA, Pigneux A, Vey N, Récher C. Garciaz S, et al. Among authors: plesa a. Am J Hematol. 2024 Oct;99(10):1870-1876. doi: 10.1002/ajh.27417. Epub 2024 Jun 20. Am J Hematol. 2024. PMID: 38899566 Free article.
Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry.
Heiblig M, Gross Z, Belhabri A, Tauveron-Jalenques U, Tavernier E, Requena Aspas G, Carré M, Contejean A, Boullanger Fow Heng N, Santana C, Rocher C, Lamure S, Pica GM, Michallet M, Cornillon J, Meunier M, Mauz N, Chraibi S, Thevenet U, Dony A, Le Meur G, Coster L, Tondeur S, Beillard E, Carillo S, Manzoni D, Flandrin P, Tassin T, Huet S, Plesa A; French AURAML group. Heiblig M, et al. Among authors: plesa a. Leukemia. 2026 Oct;40(10):2191-2201. doi: 10.1038/s41375-026-03024-y. Epub 2026 Jul 17. Leukemia. 2026. PMID: 42469476 Free PMC article.
Epigenetic approaches for cervical neoplasia screening (Review).
Albulescu A, Plesa A, Fudulu A, Iancu IV, Anton G, Botezatu A. Albulescu A, et al. Among authors: plesa a. Exp Ther Med. 2021 Dec;22(6):1481. doi: 10.3892/etm.2021.10916. Epub 2021 Oct 25. Exp Ther Med. 2021. PMID: 34765022 Free PMC article. Review.
This is not an osteoclast.
Plesa A, Sujobert P. Plesa A, et al. Blood. 2016 Oct 13;128(15):1993. doi: 10.1182/blood-2016-06-722389. Blood. 2016. PMID: 27737848 Free article. No abstract available.
LncRNAs expression profile in a family household cluster of COVID-19 patients.
Iancu IV, Diaconu CC, Plesa A, Fudulu A, Albulescu A, Neagu AI, Pitica IM, Dragu LD, Bleotu C, Chivu-Economescu M, Matei L, Mambet C, Nedeianu S, Popescu CP, Sultana C, Ruta SM, Botezatu A. Iancu IV, et al. Among authors: plesa a. J Cell Mol Med. 2024 Apr;28(7):e18226. doi: 10.1111/jcmm.18226. J Cell Mol Med. 2024. PMID: 38501860 Free PMC article.
95 results